Workout on Wheels Internet Intervention (WOWii)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT03189095|
Recruitment Status : Completed
First Posted : June 16, 2017
Last Update Posted : January 18, 2020
- Study Details
- Tabular View
- No Results Posted
- How to Read a Study Record
|Condition or disease||Intervention/treatment||Phase|
|Spinal Cord Injuries||Behavioral: WOWii (Workout on Wheels Internet Intervention)||Not Applicable|
This study will gather empirical evidence of the effectiveness of WOWii intervention in promoting changes in exercise behavior, fitness, and perceptions of exercise over the 16 week intervention as well as 2 months later for individuals living with SCI. The study staff will assess effectiveness by measuring participants (a) time spent each week doing aerobic exercise by self-report and objective monitoring, (b) aerobic capacity to assess fitness changes, and (c) self-reported perceptions of exercise barriers and self-efficacy at baseline, 4 months, and 6 months.
Participants will be randomly assigned to an experimental (WOWii) or a wait-list control group in one of four cohorts over a two-year period. This was an effective strategy in our previous trial in helping us achieve the full sample size. We will use a blocked randomization procedure to assure equal distribution of those with paraplegia and tetraplegia. Four cohorts will be enrolled over two years, with each having up to 36 people. This allows for up to 18 participants in the experimental and control groups, which permits us to offer two different time options for participants to attend the weekly meetings, as our video conferencing software allows up to 10 people to participate in the group video chat. Each cohort will be divided into two groups of 18 study participants as experimental and wait-list control groups. The experimental group will be divided into two groups of nine participants. Each cohort will begin the intervention at the same time and attend weekly calls together. All participants will undergo a pre-screen assessment which includes eligibility assessment. Participants will undergo 2 in-person fitness testing assessments at baseline at the end of the 16 week internet intervention with online meetings, before or during which they will complete an online survey and follow. A third follow up assessment will be conducted as an online survey at 6 months, which is 2 months after the intervention is complete, and an exit survey will be conducted individually over the phone after within one week of completing the final online survey. The wait-list control group will be offered the intervention at the end of the 6 month period. Due to low enrollment numbers, we will likely add a 5th cohort for enrollment.
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||168 participants|
|Intervention Model:||Parallel Assignment|
|Intervention Model Description:||The investigators opted to use a wait-list control group to serve as an untreated comparison for the experimental group. From the investigators' perspective, people calling about an exercise trial want to receive an intervention, and thus, they believe it would be unethical to deny access to the intervention. Control group participants will be asked to continue their current activity level over the 16 weeks and following their posttest, they will be invited to participate in the WOWii program in full. The investigators will examine whether differential dropouts occur between those assigned to the experimental and wait-list control groups. The investigators previous exercise study conducted among women with mobility impairment indicated slightly lower attrition in the wait list control group, with no significant differences between those who withdrew and those who remained in the study by six months.|
|Masking:||None (Open Label)|
|Official Title:||Project Workout on Wheels Internet Intervention (WOWii): Summative Evaluation With Randomized Clinical Trial|
|Actual Study Start Date :||June 6, 2017|
|Actual Primary Completion Date :||October 1, 2019|
|Actual Study Completion Date :||December 31, 2019|
Behavioral: WOWii (Workout on Wheels Internet Intervention)
Participants will self-monitor their exercise on the WOWii website, which has a page to record the type, duration, and intensity of daily exercise bouts.
Two devices will track participants' exercise, a Polar heart rate monitor (RS300X, Polar®), which will provide data on the day, duration, and intensity (average and maximum) of aerobic activity and an ActiGraph accelerometer (model GT3X), which detects movement in three planes to indicate frequency and intensity of movement throughout the day. Experimental participants will be provided a Polar heart rate monitor to wear during each exercise bout for the entire length of the 6-month study, and exercise data will be collected weekly.
Physiological outcomes on fitness will be assessed by measuring weight and aerobic capacity in a Cardiopulmonary Lab by a doctoral-trained physical therapist.
Participants will complete surveys to report on their exercise self-efficacy and perceived barriers.
|No Intervention: Wait-List Control|
- Change in aerobic exercise (Participant adoption) [ Time Frame: 16 weeks ]minutes per week measured by Polar activity tracker (objective)
- Aerobic exercise maintenance [ Time Frame: 16 weeks ]minutes per week measured by Polar activity tracker (objective)
- Change in aerobic exercise (Participant adoption) [ Time Frame: Baseline & 16 weeks ]minutes per week measured by The International Physical Activity Questionnaire (IPAQ) (subjective)
- Aerobic exercise maintenance [ Time Frame: 16 weeks ]minutes per week measured by The International Physical Activity Questionnaire (IPAQ) (subjective)
- Change in aerobic fitness [ Time Frame: Baseline & 16 weeks ]peak V02 using continuous, graded arm crank protocol
- Exercise Self-Efficacy [ Time Frame: 16 weeks ]health promotion scale with exercise subscale Self Rated Abilities for Health Practices Scale (SRAHP)
- Change in perceived exercise barriers [ Time Frame: Baseline & 16 weeks ]Change in summary score of barriers on The Barriers to Health Activities among Disabled Persons scale (BHADP) from baseline to 16 weeks
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
|Ages Eligible for Study:||18 Years to 70 Years (Adult, Older Adult)|
|Sexes Eligible for Study:||All|
|Accepts Healthy Volunteers:||Yes|
- Between the ages of 18 - 70 years old;
- Have SCI > 6 months with the ability to use arms enough for arm-based exercise and requires wheelchair use;
- Have access to a computer with internet access or if they do not have computer/internet access, have experience using a computer and going online;
- Obtain physician signed approval to participate in the exercise study; and
- Not be currently physically active, based on responses to the 7-item Behavioral Risk Factor Surveillance physical activity survey.
- Not receive physician approval to begin an exercise program;
- Have participated in the previous pilot studies; and
- Unable to read the English language.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03189095
|United States, Texas|
|Baylor Institute for Rehabilitation|
|Dallas, Texas, United States, 75246|
|Principal Investigator:||Katherine Froehlich-Grobe, Ph.D.||Baylor Institute for Rehabilitation|
|Responsible Party:||Baylor Research Institute|
|Other Study ID Numbers:||
|First Posted:||June 16, 2017 Key Record Dates|
|Last Update Posted:||January 18, 2020|
|Last Verified:||January 2020|
|Individual Participant Data (IPD) Sharing Statement:|
|Plan to Share IPD:||No|
|Studies a U.S. FDA-regulated Drug Product:||No|
|Studies a U.S. FDA-regulated Device Product:||No|
spinal cord injury
Spinal Cord Injuries
Spinal Cord Diseases
Central Nervous System Diseases
Nervous System Diseases
Trauma, Nervous System
Wounds and Injuries